147 related articles for article (PubMed ID: 25444845)
1. Statistical investigation of simulated intestinal fluid composition on the equilibrium solubility of biopharmaceutics classification system class II drugs.
Khadra I; Zhou Z; Dunn C; Wilson CG; Halbert G
Eur J Pharm Sci; 2015 Jan; 67():65-75. PubMed ID: 25444845
[TBL] [Abstract][Full Text] [Related]
2. Statistical investigation of simulated fed intestinal media composition on the equilibrium solubility of oral drugs.
Zhou Z; Dunn C; Khadra I; Wilson CG; Halbert GW
Eur J Pharm Sci; 2017 Mar; 99():95-104. PubMed ID: 27940083
[TBL] [Abstract][Full Text] [Related]
3. Small scale design of experiment investigation of equilibrium solubility in simulated fasted and fed intestinal fluid.
McPherson S; Perrier J; Dunn C; Khadra I; Davidson S; Ainousah B; Wilson CG; Halbert G
Eur J Pharm Biopharm; 2020 May; 150():14-23. PubMed ID: 32035969
[TBL] [Abstract][Full Text] [Related]
4. Small scale in vitro method to determine a bioequivalent equilibrium solubility range for fasted human intestinal fluid.
Abuhassan Q; Khadra I; Pyper K; Halbert GW
Eur J Pharm Biopharm; 2021 Nov; 168():90-96. PubMed ID: 34419602
[TBL] [Abstract][Full Text] [Related]
5. Statistical investigation of the full concentration range of fasted and fed simulated intestinal fluid on the equilibrium solubility of oral drugs.
Perrier J; Zhou Z; Dunn C; Khadra I; Wilson CG; Halbert G
Eur J Pharm Sci; 2018 Jan; 111():247-256. PubMed ID: 28987539
[TBL] [Abstract][Full Text] [Related]
6. Fasted intestinal solubility limits and distributions applied to the biopharmaceutics and developability classification systems.
Abuhassan Q; Khadra I; Pyper K; Augustijns P; Brouwers J; Halbert GW
Eur J Pharm Biopharm; 2022 Jan; 170():160-169. PubMed ID: 34923138
[TBL] [Abstract][Full Text] [Related]
7. Small scale in vitro method to determine a potential bioequivalent equilibrium solubility range for fed human intestinal fluid.
Inês Silva M; Khadra I; Pyper K; Halbert GW
Eur J Pharm Biopharm; 2022 Aug; 177():126-134. PubMed ID: 35718078
[TBL] [Abstract][Full Text] [Related]
8. Influence of Physiological Gastrointestinal Surfactant Ratio on the Equilibrium Solubility of BCS Class II Drugs Investigated Using a Four Component Mixture Design.
Zhou Z; Dunn C; Khadra I; Wilson CG; Halbert GW
Mol Pharm; 2017 Dec; 14(12):4132-4144. PubMed ID: 28749696
[TBL] [Abstract][Full Text] [Related]
9. Effect of composition of simulated intestinal media on the solubility of poorly soluble compounds investigated by design of experiments.
Madsen CM; Feng KI; Leithead A; Canfield N; Jørgensen SA; Müllertz A; Rades T
Eur J Pharm Sci; 2018 Jan; 111():311-319. PubMed ID: 28986196
[TBL] [Abstract][Full Text] [Related]
10. Topography of Simulated Intestinal Equilibrium Solubility.
Dunn C; Perrier J; Khadra I; Wilson CG; Halbert GW
Mol Pharm; 2019 May; 16(5):1890-1905. PubMed ID: 30848917
[TBL] [Abstract][Full Text] [Related]
11. Structured solubility behaviour in bioequivalent fasted simulated intestinal fluids.
Abuhassan Q; Khadra I; Pyper K; Augustijns P; Brouwers J; Halbert GW
Eur J Pharm Biopharm; 2022 Jul; 176():108-121. PubMed ID: 35605926
[TBL] [Abstract][Full Text] [Related]
12. Structured solubility behaviour in fed simulated intestinal fluids.
Silva MI; Khadra I; Pyper K; Halbert GW
Eur J Pharm Biopharm; 2023 Dec; 193():58-73. PubMed ID: 37890541
[TBL] [Abstract][Full Text] [Related]
13. Dual Level Statistical Investigation of Equilibrium Solubility in Simulated Fasted and Fed Intestinal Fluid.
Ainousah BE; Perrier J; Dunn C; Khadra I; Wilson CG; Halbert G
Mol Pharm; 2017 Dec; 14(12):4170-4180. PubMed ID: 29072917
[TBL] [Abstract][Full Text] [Related]
14. Multidimensional analysis of human intestinal fluid composition.
Pyper K; Brouwers J; Augustijns P; Khadra I; Dunn C; Wilson CG; Halbert GW
Eur J Pharm Biopharm; 2020 Aug; 153():226-240. PubMed ID: 32585351
[TBL] [Abstract][Full Text] [Related]
15. Crystallization from Supersaturated Solutions: Role of Lecithin and Composite Simulated Intestinal Fluid.
Indulkar AS; Gao Y; Raina SA; Zhang GGZ; Taylor LS
Pharm Res; 2018 Jun; 35(8):158. PubMed ID: 29916053
[TBL] [Abstract][Full Text] [Related]
16. Fed intestinal solubility limits and distributions applied to the Developability classification system.
Silva MI; Khadra I; Pyper K; Halbert GW
Eur J Pharm Biopharm; 2023 May; 186():74-84. PubMed ID: 36934829
[TBL] [Abstract][Full Text] [Related]
17. Is the full potential of the biopharmaceutics classification system reached?
Bergström CA; Andersson SB; Fagerberg JH; Ragnarsson G; Lindahl A
Eur J Pharm Sci; 2014 Jun; 57():224-31. PubMed ID: 24075971
[TBL] [Abstract][Full Text] [Related]
18. Impact of phospholipid digests and bile acid pool variations on the crystallization of atazanavir from supersaturated solutions.
Enright EF; Joyce SA; Gahan CGM; Taylor LS
Eur J Pharm Biopharm; 2020 Aug; 153():68-83. PubMed ID: 32473291
[TBL] [Abstract][Full Text] [Related]
19. Simulating fasted human intestinal fluids: understanding the roles of lecithin and bile acids.
Söderlind E; Karlsson E; Carlsson A; Kong R; Lenz A; Lindborg S; Sheng JJ
Mol Pharm; 2010 Oct; 7(5):1498-507. PubMed ID: 20698569
[TBL] [Abstract][Full Text] [Related]
20. The Biopharmaceutics Classification System: subclasses for in vivo predictive dissolution (IPD) methodology and IVIVC.
Tsume Y; Mudie DM; Langguth P; Amidon GE; Amidon GL
Eur J Pharm Sci; 2014 Jun; 57():152-63. PubMed ID: 24486482
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]